Wielka Brytania -
angielski -
MHRA (Medicines & Healthcare Products Regulatory Agency)
neo-naclex 5mg tablets
mercury pharma group ltd - bendroflumethiazide - oral tablet - 5mg
Nowa Zelandia -
angielski -
Medsafe (Medicines Safety Authority)
arrow - bendrofluazide 2.5
teva pharma (new zealand) limited - bendroflumethiazide 2.5mg; ; - tablet - 2.5 mg - active: bendroflumethiazide 2.5mg excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.
Nowa Zelandia -
angielski -
Medsafe (Medicines Safety Authority)
arrow - bendrofluazide 5
teva pharma (new zealand) limited - bendroflumethiazide 5mg; ; - tablet - 5 mg - active: bendroflumethiazide 5mg excipient: lactose purified talc starch stearic acid - bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.
Irlandia -
angielski -
HPRA (Health Products Regulatory Authority)
centyl k 2.5 mg/573 mg modified-release tablets
leo laboratories limited - bendroflumethiazide; potassium chloride - modified-release tablet - 2.5/573 milligram(s) - thiazides and potassium in combination; bendroflumethiazide and potassium
Irlandia -
angielski -
HPRA (Health Products Regulatory Authority)
low centyl k 1.25 mg/573 mg modified-release tablets
leo laboratories limited - bendroflumethiazide; potassium chloride - modified-release tablet - 1.25/573 milligram(s) - thiazides and potassium in combination; bendroflumethiazide and potassium
Irlandia -
angielski -
HPRA (Health Products Regulatory Authority)
centyl k 2.5 mg/573 mg modified-release tablets
karo pharma ab - bendroflumethiazide; potassium chloride - modified-release tablet - 2.5/573 milligram(s) - thiazides and potassium in combination; bendroflumethiazide and potassium
Irlandia -
angielski -
HPRA (Health Products Regulatory Authority)
low centyl k 1.25 mg/573 mg modified-release tablets
karo pharma ab - bendroflumethiazide; potassium chloride - modified-release tablet - 1.25/573 milligram(s) - thiazides and potassium in combination; bendroflumethiazide and potassium
Wielka Brytania -
angielski -
MHRA (Medicines & Healthcare Products Regulatory Agency)
urizide 5mg tablets
dr reddy's laboratories (uk) ltd - bendroflumethiazide - oral tablet - 5mg
Wielka Brytania -
angielski -
MHRA (Medicines & Healthcare Products Regulatory Agency)
urizide 2.5mg tablets
dr reddy's laboratories (uk) ltd - bendroflumethiazide - oral tablet - 2.5mg
Wielka Brytania -
angielski -
MHRA (Medicines & Healthcare Products Regulatory Agency)
aprinox 5mg tablets
amdipharm plc - bendroflumethiazide - oral tablet - 5mg